183 related articles for article (PubMed ID: 36533953)
21. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
Kim YJ; Cubitt B; Chen E; Hull MV; Chatterjee AK; Cai Y; Kuhn JH; de la Torre JC
Antiviral Res; 2019 Sep; 169():104558. PubMed ID: 31302150
[TBL] [Abstract][Full Text] [Related]
22. Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.
Penaloza MacMaster P; Shields JL; Alayo QA; Cabral C; Jimenez J; Mondesir J; Chandrashekar A; Cabral JM; Lim M; Iampietro MJ; Provine NM; Bricault CA; Seaman M; Orlinger K; Aspoeck A; Fuhrmann G; Lilja AE; Monath T; Mangeat B; Pinschewer DD; Barouch DH
Vaccine; 2017 Jan; 35(1):1-9. PubMed ID: 27899229
[TBL] [Abstract][Full Text] [Related]
23. Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.
Iwasaki M; Ng CT; Cubitt B; de la Torre JC
J Virol; 2016 Nov; 90(22):10102-10112. PubMed ID: 27581982
[TBL] [Abstract][Full Text] [Related]
24. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
[TBL] [Abstract][Full Text] [Related]
25. Plasmid-Based Lassa Virus Reverse Genetics.
Martínez-Sobrido L; Ye C; de la Torre JC
Methods Mol Biol; 2024; 2733():115-131. PubMed ID: 38064030
[TBL] [Abstract][Full Text] [Related]
26. Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.
Takayama-Ito M; Lim CK; Yamaguchi Y; Posadas-Herrera G; Kato H; Iizuka I; Islam MT; Morimoto K; Saijo M
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006398. PubMed ID: 29659579
[TBL] [Abstract][Full Text] [Related]
27. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.
Pinschewer DD; Perez M; Sanchez AB; de la Torre JC
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7895-900. PubMed ID: 12808132
[TBL] [Abstract][Full Text] [Related]
28. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.
Flatz L; Hegazy AN; Bergthaler A; Verschoor A; Claus C; Fernandez M; Gattinoni L; Johnson S; Kreppel F; Kochanek S; Broek Mv; Radbruch A; Lévy F; Lambert PH; Siegrist CA; Restifo NP; Löhning M; Ochsenbein AF; Nabel GJ; Pinschewer DD
Nat Med; 2010 Mar; 16(3):339-45. PubMed ID: 20139992
[TBL] [Abstract][Full Text] [Related]
29. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication.
Pinschewer DD; Perez M; de la Torre JC
J Virol; 2003 Mar; 77(6):3882-7. PubMed ID: 12610166
[TBL] [Abstract][Full Text] [Related]
30. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
[TBL] [Abstract][Full Text] [Related]
31. Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against
Belnoue E; Vogelzang A; Nieuwenhuizen NE; Krzyzaniak MA; Darbre S; Kreutzfeldt M; Wagner I; Merkler D; Lambert PH; Kaufmann SHE; Siegrist CA; Pinschewer DD
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269842
[No Abstract] [Full Text] [Related]
32. Activation of protein kinase receptor (PKR) plays a pro-viral role in mammarenavirus-infected cells.
Witwit H; Khafaji R; Salaniwal A; Kim AS; Cubitt B; Jackson N; Ye C; Weiss SR; Martinez-Sobrido L; de la Torre JC
J Virol; 2024 Mar; 98(3):e0188323. PubMed ID: 38376197
[TBL] [Abstract][Full Text] [Related]
33. Pseudotyped Viruses for Mammarenavirus.
Li Q; Huang W; Wang Y
Adv Exp Med Biol; 2023; 1407():279-297. PubMed ID: 36920703
[TBL] [Abstract][Full Text] [Related]
34. Arenavirus Quasispecies and Their Biological Implications.
Grande-Pérez A; Martin V; Moreno H; de la Torre JC
Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
[TBL] [Abstract][Full Text] [Related]
35. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
[TBL] [Abstract][Full Text] [Related]
36. The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity.
Darbre S; Johnson S; Kallert S; Lambert PH; Siegrist CA; Pinschewer DD
J Virol; 2015 Nov; 89(22):11734-8. PubMed ID: 26355095
[TBL] [Abstract][Full Text] [Related]
37. Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.
Mantlo EK; Maruyama J; Manning JT; Wanninger TG; Huang C; Smith JN; Patterson M; Paessler S; Koma T
J Virol; 2022 Apr; 96(8):e0020922. PubMed ID: 35343792
[TBL] [Abstract][Full Text] [Related]
38. Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.
Sommerstein R; Ramos da Palma J; Olschläger S; Bergthaler A; Barba L; Lee BP; Pasquato A; Flatz L
J Virol; 2014 Aug; 88(15):8340-8. PubMed ID: 24829355
[TBL] [Abstract][Full Text] [Related]
39. Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge.
Krolik M; Csepregi L; Hartmann F; Engetschwiler C; Flatz L
Vaccine; 2021 Feb; 39(8):1257-1264. PubMed ID: 33518468
[TBL] [Abstract][Full Text] [Related]
40. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
